Monday, August 3, 2015| Latest E-book
You are here:
Pharmaceuticals in India
#

Pharmaceuticals in India

Articles

100% FDI in pharma sector bad for country: Parl committee

Aug 15, 2013

100% FDI in pharma sector bad for country: Parl committee

The Parliamentary Committee on Commerce on FDI in the pharmaceutical sector has asked the government to impose a blanket ban on foreign investment in brownfield pharma projects. #ToTheContrary #Pharmaceuticals in India #Foreign direct investment #FDI #FDI in Pharma #Parliamentary Committee on Commerce on FDI
Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

Jun 09, 2013

Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

The $500 million fine on Ranbaxy by US authorities after it pleaded guilty to "felony charges" for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry, according to Biocon Chairman and Manging Director Kiran Mazumdar-Shaw. #Pharmaceuticals in India #TheySaidIt #Ranbaxy #Kiran Mazumdar-Shaw
'New drug policy to negatively impact investment in pharmas'

May 17, 2013

'New drug policy to negatively impact investment in pharmas'

"At a company level, we were aware of the upcoming policy and have factored in the impact which is likely to be in the range of 3-4 per cent of our finished dosage sales in India. We have plans in place to ride over this impact," Dr Reddy's Laboratories Vice-Chairman and MD Satish Reddy said. #Pharmaceuticals in India #WhoSaidWhat #Dr. Reddy's Laboratories #drug policy
IT services, pharma likely to be biggest employers in 2013

Dec 27, 2012

IT services, pharma likely to be biggest employers in 2013

Information Technology services and pharmaceuticals are likely to drive hiring growth in 2013, to fill mid and senior positions, said HeadHonchos.com, a leading job search and career management portal. #Pharmaceuticals in India #jobs #Employment #Information technology #2013 #FastForward2013
'Patent drug prices should be set after negotiations with pharma cos'

Sep 07, 2012

'Patent drug prices should be set after negotiations with pharma cos'

According to industry estimates, there are around 18 patented drugs being marketed in India with a total market value of around Rs 4,000 crore to Rs 5,000 crore, about 12 percent of the overall domestic market #Pharmaceuticals in India #ToWhatEffect #parliamentary panel #Drug companies
Sun Pharma gains from rupee fall, lower competition in US

Aug 13, 2012

Sun Pharma gains from rupee fall, lower competition in US

All business segments recorded strong performances with the US segment recording maximum growth. #US #Pharmaceuticals in India #Sun Pharmaceuticals #StockWatch #Taro #Rupee fall
Divi's Laboratories Q1 net jumps 63% to Rs 167 crore

Aug 06, 2012

Divi's Laboratories Q1 net jumps 63% to Rs 167 crore

Pharmaceuticals firm Divi's Laboratories reported 63.15 percent increase in standalone net profit for the quarter ended 30 June, 2012 at Rs 167.38 crore, driven by higher sales realisation. #Pharmaceuticals in India #EarningsShow #Divi's Labs #Q1 Results
Sun Pharma to consider internal restructuring of business

Aug 06, 2012

Sun Pharma to consider internal restructuring of business

The Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August "would consider the internal restructuring of the business of the company with effect from 31 March, 2012". #restructuring #Pharmaceuticals in India #CorporateStrategy #SunPharma
Ranbaxy gains after launching hybrid business model in Venezuela

Jun 20, 2012

Ranbaxy gains after launching hybrid business model in Venezuela

Japanese pharma major Daiichi Sankyo will sell Ranbaxy's drugs in Venezuela expanding its portfolio of medicines to promote the hybrid business model. #Ranbaxy Laboratories #Pharmaceuticals in India #CompanyWatch #Daiichi Sankyo
Piramal Healthcare: Please take note of displeasure

May 07, 2011

Piramal Healthcare: Please take note of displeasure

Piramal is sitting on a pile of cash and if put to sensible use, the shareholders will definitely benefit. But what is the company's objective? Will it remain a conglomerate or not? #Numbers #Ajay Piramal #Pharmaceuticals in India #Piramal Life Sciences #Indiareit Fund #Indiareit Investment Management Company #Piramal Healthcare